References
- Adams LV, Waddell RD, Fordham Von Reyn C. T-SPOT. TB Test® results in adults with Mycobacterium avium complex pulmonary disease. Scand J Infect Dis. 2008;40(3):196–203. doi:10.1080/00365540701642179 Medline
- Adzic-Vukicevic T, Barac A, Blanka-Protic A, Laban-Lazovic M, Lukovic B, Skodric-Trifunovic V, Rubino S. Clinical features of infection caused by non-tuberculous mycobacteria: 7 years’ experience. Infection. 2018;46(3):357–363. doi:10.1007/s15010-018-1128-2 Medline
- Bakuła Z, Kościuch J, Safianowska A, Proboszcz M, Bielecki J, van Ingen J, Krenke R, Jagielski T. Clinical, radiological and molecular features of Mycobacterium kansasii pulmonary disease. Respir Med. 2018;139:91–100. doi:10.1016/j.rmed.2018.05.007 Medline
- Borkowska D, Zwolska Z, Michałowska-Mitczuk D, Korzeniewska-Koseła M, Zabost A, Napiórkowska A, Kozińska M, Brzezińska S, Augustynowicz-Kopeć E. [Interferon-gamma assays T-SPOT.TB for the diagnosis of latent tuberculosis infection] (in Polish). Pneumonol Alergol Pol. 2011;79(4):264–271. Medline
- Borkowska DI, Napiórkowska AM, Brzezińska SA, Kozińska M, Zabost AT, Augustynowicz-Kopeć EM. From latent tuberculosis infection to tuberculosis. News in diagnostics (QuantiFERON-Plus). Pol J Microbiol. 2017;66(1):5–8. doi:10.5604/17331331.1234987 Medline
- Demkow U. [Interferon gamma based tests as a new tool in diagnosis of latent tuberculosis] (in Polish). Pneumonol Alergol Pol. 2011;79(4):261–263. Medline
- European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2016–2018. Stockholm (Sweden): European Centre for Disease Prevention and Control. 2018.
- Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, et al.; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of non-tuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416. doi:10.1164/rccm.200604-571ST Medline
- Korzeniewska-Koseła M (editor). Gruźlica i choroby układu oddechowego w Polsce w 2017 roku. Warszawa (Poland): Instytut Gruźlicy i Chorób Płuc. 2018.
- Haworth CS, Banks J, Capstick T, Fisher AJ, Gorsuch T, Laurenson IF, Leitch A, Loebinger MR, Milburn HJ, Nightingale M, et al. British Thoracic Society guidelines for the management of nontuberculous mycobacterial pulmonary disease (NTM-PD). Thorax. 2017;72 Suppl 2:ii1–ii64. doi:10.1136/thoraxjnl-2017-210927 Medline
- Hermansen TS, Thomsen VØ, Lillebaek T, Ravn P. Non-tuberculous mycobacteria and the performance of interferon gamma release assays in Denmark. PLoS One. 2014;9(4):e93986. doi:10.1371/journal.pone.0093986 Medline
- Hoefsloot W, van Ingen J, Andrejak C, Ängeby K, Bauriaud R, Bemer P, Beylis N, Boeree MJ, Cacho J, Chihota V, et al.; Nontuberculous Mycobacteria Network European Trials Group. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J. 2013;42(6):1604–1613. doi:10.1183/09031936.00149212 Medline
- Klatt M, Zabost A, Augustynowcz-Kopeć E. Diagnostyka mikrobiologiczna gruźlicy z zastosowaniem testów genetycznych XPERT MTB/RIF. Zakażenia. 2015;15(6):85–92.
- Kobashi Y, Mouri K, Yagi S, Obase Y, Miyashita N, Okimoto N, Matsushima T, Kageoka T, Oka M. Clinical evaluation of the Quanti FERON-TB Gold test in patients with non-tuberculous mycobacterial disease. Int J Tuberc Lung Dis. 2009;13(11):1422–1426. Medline
- Korzeniewska-Koseła M. Tuberculosis in Poland in 2015. Przegl Epidemiol. 2017;71(3):391–403. Medline
- Kuś J, Demkow U, Lewandowska K, Korzeniewska-Koseła M, Rabczenko D, Siemion-Szcześniak I, Białas-Chromiec B, Bychawska M, Sapigórski P, Maciejewski J. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10]. Pneumonol Alergol Pol. 2011;79(6):407–418. Medline
- Mancuso JD, Mazurek GH, Tribble D, Olsen C, Aronson NE, Geiter L, Goodwin D, Keep LW. Discordance among commercially available diagnostics for latent tuberculosis infection. Am J Respir Crit Care Med. 2012;185(4):427–434. doi:10.1164/rccm.201107-1244OC Medline
- Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, Montes de Oca R, Shea YR, Seitz AE, Holland SM, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med. 2010;182(7):970–976. doi:10.1164/rccm.201002-0310OC Medline
- Ra SW, Lyu J, Choi C-M, Oh Y-M, Lee S-D, Kim WS, Kim DS, Shim TS. Distinguishing tuberculosis from Mycobacterium avium complex disease using an interferon-gamma release assay. Int J Tuberc Lung Dis. 2011;15(5):635–640. doi:10.5588/ijtld.10.0485 Medline
- Sato R, Nagai H, Matsui H, Kawabe Y, Takeda K, Kawashima M, Suzuki J, Ohshima N, Masuda K, Yamane A, et al. Interferongamma release assays in patients with Mycobacterium kansasii pulmonary infection: A retrospective survey. J Infect. 2016;72(6): 706–712. doi:10.1016/j.jinf.2016.03.011 Medline
- Słupek A, Zwolska Z, Miller M, Rowińska-Zakrzewska E. [Pulmonary mycobacteriosis-diagnostic problem and prevalence in Poland (a retrospective study)]. (in Polish). Pneumonol Alergol Pol. 1997;65(5–6):326–332. Medline
- van der Werf MJ, Ködmön C, Katalinić-Janković V, Kummik T, Soini H, Richter E, Papaventsis D, Tortoli E, Perrin M, van Soolingen D, et al. Inventory study of non-tuberculous mycobacteria in the European Union. BMC Infect Dis. 2014;14(1):62–70. doi:10.1186/1471-2334-14-62 Medline
- Wang MS, Wang JL, Wang XF. The performance of interferongamma release assay in nontuberculous mycobacterial diseases: a retrospective study in China. BMC Pulm Med. 2016;16(1):163. doi:10.1186/s12890-016-0320-3 Medline
- Wilińska E, Oniszh K, Augustynowicz-Kopeć E, Zabost A, Fijałkowska A, Kurzyna M, Wieteska M, Torbicki A, Kuś J, Szturmowicz M. Non-tuberculous mycobacterial lung disease (NTMLD) in patients with chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension. Pneumonol Alergol Pol. 2014;82(6):495–502. doi:10.5603/PiAP.2014.0066 Medline
- Zabost A, Augustynowicz-Kopeć E. Use of GenoType MTBDR plus assay for the detection of mycobacteria molecular rifampicin and isoniazid resistance. Post Nauk Med. 2015;4:249–254.